| EP2797959 - ASPARTYL-TRNA SYNTHETASE-FC CONJUGATES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.11.2019 Database last updated on 28.03.2026 | |
| Former | Examination is in progress Status updated on 16.12.2016 | Most recent event Tooltip | 01.11.2019 | Application deemed to be withdrawn | published on 04.12.2019 [2019/49] | Applicant(s) | For all designated states Atyr Pharma, Inc. 3545 John Hopkins Court, Suite No. 250 San Diego, CA 92121 / US | [2014/45] | Inventor(s) | 01 /
BUECHLER, Ying Ji 1343 Cassins Street Carlsbad California 92011 / US | 02 /
WU, Chi-Fang 2649 Villas Way San Diego California 92108 / US | 03 /
ADAMS, Ryan A. 1260 Diamond Street San Diego California 92109 / US | 04 /
WATKINS, Jeffry D. 3442 Fortuna Ranch Road Encinitas California 92024 / US | 05 /
MENDLEIN, John D. 1550 Neptune Avenue Encinitas California 92024 / US | [2014/45] | Representative(s) | Høiberg P/S Adelgade 12 1304 Copenhagen K / DK | [N/P] |
| Former [2014/45] | Høiberg A/S St. Kongensgade 59 A 1264 Copenhagen K / DK | Application number, filing date | 12867497.5 | 27.12.2012 | WO2012US71762 | Priority number, date | US201161581550P | 29.12.2011 Original published format: US 201161581550 P | [2014/45] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013115926 | Date: | 08.08.2013 | Language: | EN | [2013/32] | Type: | A2 Application without search report | No.: | EP2797959 | Date: | 05.11.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.08.2013 takes the place of the publication of the European patent application. | [2014/45] | Search report(s) | International search report - published on: | KR | 31.10.2013 | (Supplementary) European search report - dispatched on: | EP | 24.07.2015 | Classification | IPC: | C07K19/00, A61K38/16, C12N15/62, A61P35/00, A61K38/00, C12N9/00, C07K16/00 | [2015/22] | CPC: |
C12N9/93 (EP,US);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
C07K16/00 (US);
C12Y601/01012 (EP,US);
A61K38/00 (EP,US);
C07K2319/02 (EP,US);
C07K2319/21 (EP,US);
C07K2319/30 (EP,US);
C07K2319/50 (EP,US);
|
| Former IPC [2014/45] | C07K19/00, A61K38/16, C12N15/62, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/45] | Title | German: | ASPARTYL-TRNA-SYNTHETASE-FC-KONJUGATE | [2014/45] | English: | ASPARTYL-TRNA SYNTHETASE-FC CONJUGATES | [2014/45] | French: | CONJUGUÉS ASPARTYL-ARNT SYNTHÉTASE-FC | [2014/45] | Entry into regional phase | 29.07.2014 | National basic fee paid | 29.07.2014 | Search fee paid | 29.07.2014 | Designation fee(s) paid | 29.07.2014 | Examination fee paid | Examination procedure | 29.07.2014 | Examination requested [2014/45] | 17.02.2016 | Amendment by applicant (claims and/or description) | 16.12.2016 | Despatch of a communication from the examining division (Time limit: M06) | 02.10.2017 | Reply to a communication from the examining division | 14.05.2018 | Despatch of a communication from the examining division (Time limit: M04) | 06.09.2018 | Reply to a communication from the examining division | 02.07.2019 | Application deemed to be withdrawn, date of legal effect [2019/49] | 29.07.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2019/49] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 16.12.2016 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 02.10.2017 | Request for further processing filed | 02.10.2017 | Full payment received (date of receipt of payment) Request granted | 16.10.2017 | Decision despatched | Fees paid | Renewal fee | 17.12.2014 | Renewal fee patent year 03 | 28.12.2015 | Renewal fee patent year 04 | 27.12.2016 | Renewal fee patent year 05 | 27.12.2017 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.12.2018 | 07   M06   Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI] WO2010120509 (ATYR PHARMA INC et al.) [X] 1,7,8,11-15 * abstract * * page 1, paragraph 3 * * page 3, paragraph 3 - page 7, paragraph 4 * * page 33, paragraph 1 * * page 35, paragraph 4 * * page 99 - page 112 * * claims 1-6,9,10,29-37 * * sequence 1 *[I] 5,6,9,10 | [XP] WO2012009289 (ATYR PHARMA INC et al.) [XP] 1,7,8,11-15 * abstract * * paragraphs [0003] , [0009] , [0118] , [0166] , [0408] , [0433] * * tables 1, 3 * * sequences 12, 50 * | [Y] US2003166241 (FAMODU OMOLAYO O et al.) [Y] 1,5-15 * abstract * * paragraphs [0006] - [0010] * * sequence 25 * | [E] WO2013086216 (ATYR PHARMA INC et al.) [E] 1,4-15 * abstract * * page 1, paragraph 3 * * page 4, paragraph 5 * * page 5, paragraph 6 * * page 7, paragraph 2 - page 8, paragraph 3 * * page 64, paragraph 4 * * sequences 4, 89 * | [Y] DUMONT JENNIFER A ET AL: "MONOMERIC FC FUSIONS: IMPACT ON PHARMACOKINETIC AND BIOLOGICAL ACTIVITY OF PROTEIN THERAPEUTICS", BIODRUGS: CLINICAL IMMUNOTHERAPEUTICS, BIOPHARMACEUTICALS AND GENE THERAPY, ADIS INTERNATIONAL, FR, vol. 20, no. 3, 1 January 2006 (2006-01-01), pages 151 - 160, XP009082835, ISSN: 1173-8804, DOI: 10.2165/00063030-200620030-00002 [Y] 1,5-15 * the whole document * DOI: http://dx.doi.org/10.2165/00063030-200620030-00002 |